Secondary prevention in coronary heart disease: Goal achievement and drug prescribing

Pharmacy World and Science

Volumn 27, Issue 6, 2005, Pages 472-474

  Giverhaug, Trude ^a   Bruland, Christine ^a   Trovik, Thor ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Coronary heart disease; Norway; Percutaneous coronary interventions; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL CHEMISTRY; CLINICAL PRACTICE; DATA BASE; DIABETES MELLITUS; FEMALE; HOSPITAL; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; RETROSPECTIVE STUDY; SECONDARY PREVENTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CORONARY DISEASE; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; RECURRENCE;

EID: 28944436916     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-005-1312-1     Document Type: Article

References (9)

1. SD Fihn MPH Sankey J Daley RJ Gibbons 2001 Guidelines for the management of patients with chronic stable angina: treatment Ann Intern Med 135 616 32
2. ME Van der Elst H Buurma ML Bouvy A de Boer 2003 Drug therapy for prevention of recurrent myocardial infarction Ann Pharmacother 37 1465 77
3. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo 2003 The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure JAMA 289 19 2560 72
4. 2003 European society of hypertension - European society of cardiology guidelines for the management of arterial hypertension. Guidelines committee. J Hypertens 2003; 21: 1011-53
5. B Williams NR Poulter MJ Brown M Davis GT [tmp] McInnes JF Potter 2004 British hypertension society guidelines for hypertension management 2004 (BHS-IV): summary BMJ 328 634 40
6. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46
7. D Wood G De Backer O Færgeman I Graham G Mancia K Pyörälä 1998 Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention Eur Heart J 19 1434 503
8. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 2003; 26: S5-20
9. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22